132 related articles for article (PubMed ID: 26181363)
21. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
[TBL] [Abstract][Full Text] [Related]
22. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
[TBL] [Abstract][Full Text] [Related]
23. GTP-dependent recruitment of CIITA to the class II major histocompatibility complex promoter.
Bewry NN; Bolick SC; Wright KL; Harton JA
J Biol Chem; 2007 Sep; 282(36):26178-84. PubMed ID: 17623662
[TBL] [Abstract][Full Text] [Related]
24. N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA.
Schnappauf F; Hake SB; Camacho Carvajal MM; Bontron S; Lisowska-Grospierre B; Steimle V
Eur J Immunol; 2003 Aug; 33(8):2337-47. PubMed ID: 12884309
[TBL] [Abstract][Full Text] [Related]
25. CREB and phospho-CREB interact with RFX5 and CIITA to regulate MHC class II genes.
Lochamy J; Rogers EM; Boss JM
Mol Immunol; 2007 Feb; 44(5):837-47. PubMed ID: 16730065
[TBL] [Abstract][Full Text] [Related]
26. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
[TBL] [Abstract][Full Text] [Related]
28. The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in myelomonocytic cells.
De Lerma Barbaro A; Procopio FA; Mortara L; Tosi G; Accolla RS
Eur J Immunol; 2005 Feb; 35(2):603-11. PubMed ID: 15627980
[TBL] [Abstract][Full Text] [Related]
29. Leucine-rich repeats of the class II transactivator control its rate of nuclear accumulation.
Harton JA; O'Connor W; Conti BJ; Linhoff MW; Ting JP
Hum Immunol; 2002 Jul; 63(7):588-601. PubMed ID: 12072194
[TBL] [Abstract][Full Text] [Related]
30. Pathologic expression of MHC class II is driven by mitogen-activated protein kinases.
Martins I; Deshayes F; Baton F; Forget A; Ciechomska I; Sylla K; Aoudjit F; Charron D; Al-Daccak R; Alcaide-Loridan C
Eur J Immunol; 2007 Mar; 37(3):788-97. PubMed ID: 17304627
[TBL] [Abstract][Full Text] [Related]
31. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of class II transactivator regulates its interaction ability and transactivation function.
Sisk TJ; Nickerson K; Kwok RP; Chang CH
Int Immunol; 2003 Oct; 15(10):1195-205. PubMed ID: 13679389
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines.
Li G; Harton JA; Zhu X; Ting JP
Mol Cell Biol; 2001 Jul; 21(14):4626-35. PubMed ID: 11416140
[TBL] [Abstract][Full Text] [Related]
34. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
[TBL] [Abstract][Full Text] [Related]
35. γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression.
Kämper N; Franken S; Temme S; Koch S; Bieber T; Koch N
FASEB J; 2012 Jan; 26(1):104-16. PubMed ID: 21940994
[TBL] [Abstract][Full Text] [Related]
36. SIRT1 links CIITA deacetylation to MHC II activation.
Wu X; Kong X; Chen D; Li H; Zhao Y; Xia M; Fang M; Li P; Fang F; Sun L; Tian W; Xu H; Yang Y; Qi X; Gao Y; Sha J; Chen Q; Xu Y
Nucleic Acids Res; 2011 Dec; 39(22):9549-58. PubMed ID: 21890893
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
Shi B; Vinyals A; Alia P; Broceño C; Chen F; Adrover M; Gelpi C; Price JE; Fabra A
Int J Biochem Cell Biol; 2006; 38(4):544-62. PubMed ID: 16343978
[TBL] [Abstract][Full Text] [Related]
38. Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
Otten LA; Leibundgut-Landmann S; Huarte J; Kos-Braun IC; Lavanchy C; Barras E; Borisch B; Steimle V; Acha-Orbea H; Reith W
Eur J Immunol; 2006 Jun; 36(6):1548-58. PubMed ID: 16703565
[TBL] [Abstract][Full Text] [Related]
39. Regulating the activity of class II transactivator by posttranslational modifications: exploring the possibilities.
Wu X; Kong X; Luchsinger L; Smith BD; Xu Y
Mol Cell Biol; 2009 Nov; 29(21):5639-44. PubMed ID: 19720744
[TBL] [Abstract][Full Text] [Related]
40. The 19S ATPase S6a (S6'/TBP1) regulates the transcription initiation of class II transactivator.
Truax AD; Koues OI; Mentel MK; Greer SF
J Mol Biol; 2010 Jan; 395(2):254-69. PubMed ID: 19853614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
